Analysis of the usage of structural fat emulsion and medium/long chain fat emulsion in China in 2016
10.13699/j.cnki.1001-6821.2019.07.032
- VernacularTitle:2016年我国医保患者结构脂肪乳和中/长链脂肪乳的使用分析
- Author:
Xue-Lin SUN
1
;
Jun-Ling L
;
Ya-Tong ZHANG
;
Yi-Fang PEI
;
Xin HU
Author Information
1. 北京医院 药学部/国家老年医学中心/药物临床风险与个体化应用评价北京市重点实验室
- Keywords:
structural fat emulsion;
medium/long chain fat emulsion;
analysis
- From:
The Chinese Journal of Clinical Pharmacology
2019;35(7):709-711
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the usage of structural fat emulsion and medium/long chain fat emulsion, so as to provide reference for promoting its rational use. Methods The demographic data of structural fat emulsion and medium/long chain fat emulsion were sampled from national medical insurance for cities and towns in 2016, demographic characteristics and disease constitution of two fat emulsion patients were statistically analyzed. Results There are statistical differences in the type of insurance, regional distribution and urban grade of the two kinds of drugs used in the structural fat emulsion and medium/long chain fat emulsion.The operation patients are far higher than the non operative group. Structural fat emulsion and medium/long chain fat emulsion were used in the surgical group, and there were statistical differences in the regional, urban and urban levels. The two type of fat emulsion is mainly used for cancer and digestive system diseases. Conclusion The overall usage of structural fat emulsion and medium/long chain fat emulsion is reasonable. It is necessary to further strengthen the rational evaluation of its clinical use.
